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Abstract
Background: The transcription factor Pax6 is essential for the development of the central nervous system and it
exerts its multiple functions by regulating the expression of downstream target molecules. To screen for genes
downstream of Pax6, we performed comprehensive transcriptome profiling analyses in the early hindbrain of Pax6
homozygous mutant and wild-type rats using microarrays.
Results: Comparison of quadruplicate microarray experiments using two computational methods allowed us to
identify differentially expressed genes that have relatively small fold changes or low expression levels. Gene
ontology analyses of the differentially expressed molecules demonstrated that Pax6 is involved in various signal
transduction pathways where it regulates the expression of many receptors, signaling molecules, transporters and
transcription factors. The up- or down-regulation of these genes was further confirmed by quantitative RT-PCR. In
situ staining of Fabp7, Dbx1, Unc5h1 and Cyp26b1 mRNAs showed that expression of these transcripts not only
overlapped with that of Pax6 in the hindbrain of wild-type and Pax6 heterozygous mutants, but also was clearly
reduced in the hindbrain of the Pax6 homozygous mutant. In addition, the Pax6 homozygous mutant hindbrain
showed that Cyp26b1 expression was lacked in the dorsal and ventrolateral regions of rhombomeres 5 and 6, and
that the size of rhombomere 5 expanded rostrocaudally.
Conclusions: These results indicate that Unc5h1 and Cyp26b1 are novel candidates for target genes transactivated
by Pax6. Furthermore, our results suggest the interesting possibility that Pax6 regulates anterior-posterior patterning
of the hindbrain via activation of Cyp26b1, an enzyme that metabolizes retinoic acid.
Background
Pax6 is a highly conserved transcription factor that con-
tains two DNA-binding domains, i.e., a paired domain
(PD) and a homeodomain. Pax6 has been identified as
an essential regulator for the development of the central
nervous system (CNS), eyes, nose, pancreas and pituitary
gland, mostly through study of the phenotypes of several
mouse and rat lines that possess either a spontaneous or
an artificial mutation in their Pax6 gene. Although Pax6
heterozygous mutant mice/rats with a semi-dominant
mutation are known as Small eye (Sey) mutants and can
be bred, their homozygous mutant embryos die soon
after birth and exhibit severe phenotypes such as a lack
of eyes and nose as well as brain malformation. One of
the rat Small eye strains, rSey
2, has a spontaneous sin-
gle-base insertion in the coding region of Pax6 that cre-
ates an abnormal stop codon downstream of the PD [1].
However, in Western blot analysis using an antibody
against the PD of Pax6, truncated Pax6 protein was not
detected in homozygous (rSey
2/rSey
2) embryos, although
we detected truncated Pax6 protein in E10.5 Sey/Sey
mice [2]. Therefore, rSey
2/rSey
2 embryos are suitable
models for analyzing the role of the Pax6 transcription
factor.
In the development of the mammalian brain, Pax6 is
expressed in specific spatiotemporal patterns. Pax6 is
expressed in proliferating neuroepithelial cells immedi-
ately prior to the onset of neurogenesis on embryonic
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and is localized to the forebrain, hindbrain and spinal
cord. Pax6 regulates a variety of developmental events,
including the patterning of the forebrain, hindbrain and
spinal cord as well as subsequent neuronal specification,
formation of neural circuits and neuronal migration [3].
Furthermore, Pax6 is involved in neurogenesis, i.e., the
proliferation of neural stem/progenitor cells and produc-
tion of neurons [4-6], and also in the differentiation of
astrocytes [7]. The multiple functions of Pax6 are very
likely exerted through the activation of its various down-
stream target genes.
We previously used DNA microarray analysis to
demonstrate that the brain-type fatty acid binding pro-
tein (Fabp7) gene is markedly down-regulated in both
the forebrain and the hindbrain of E12.5 rSey
2/rSey
2 rats
(which correspond to E10.5 mice) and is required for
the maintenance of proliferating neural stem cells in the
developing rat cortex [8]. Three other DNA microarray
studies comparing the developing telencephalon of the
Pax6 mutant mouse with that of the wild-type (WT)
identified other Pax6 downstream genes such as mEvf1
[9], Ctnnd2 (δ-catenin)[ 1 0 ] ,Starb2, Nfia, AP-2g, Neu-
roD6, Ngn2, Tbr2, Bhlhb5 and the retinoic acid (RA)
signaling molecule Rlbp1 [11]. Recently, Pax6 target
genes were identified in the developing mouse neocortex
using ChIP-chip analysis in combination with transcrip-
tome analyses, revealing Pax6-regulated transcriptional
networks in the E12.5 mouse cortex [12]. Compared
with these telencephalon data, less information exists on
downstream genes of Pax6 in the hindbrain, although
Pax6 is crucial in the development of hindbrain motor
neurons, the cerebellum and the precerebellar nuclei
[1,13-18].
In this study, we analyzed the transcriptome profiles
of E11.5 rSey
2/rSey
2 and WT rats to comprehensively
identify downstream genes of Pax6 in the early stage of
hindbrain development. Wew e r ea b l et os e l e c tg e n e s
with significantly different expression using quadrupli-
cate microarray data processed via two comparative ana-
lyses; we then confirmed the fold changes using
quantitative RT-PCR. Gene ontology analyses revealed
that a number of the differentially expressed genes
encode signaling molecules as well as transcription fac-
tors related to development. Detailed analyses of the
expression patterns of these downstream genes, includ-
ing Dbx1, Unc5h1 and Cyp26b1, as well as several hind-
brain-specific markers unexpectedly revealed
anteroposterior patterning defects in the rSey
2/rSey
2
hindbrain that may be related to altered expression of
Cyp26b1, a retinoic acid (RA)-metabolizing enzyme.
Results
Comprehensive transcriptome analyses in E11.5 rSey
2/
rSey
2 and WT rat hindbrains
We performed the microarray experiments using Gene-
Chip Rat Expression Set 230 (RAE230A and RAE230B),
which contains about 30,000 probe sets that are
expected to cover almost all genes. The two methods of
comprehensive transcriptome analyses are shown in
Additional file 1. Four sets of rSey
2/rSey
2 and WT ‘tar-
get’ samples were prepared from mRNA independently
extracted from 40 hindbrains of E11.5 embryos and
were subjected to comparison analyses using Microarray
Suite (MAS). In parallel, raw data derived from eight
absolute analyses per sub-chip by MAS were exported
to GeneSpring, normalized, averaged and compared.
Ideally, each of the two fold-change values from both
procedures should match.
All genes on the arrays were plotted on a logarithmic
scale in Figure 1A according to their normalized signal
intensities in the hindbrain of E11.5 WT (horizontal
axis) and rSey
2/rSey
2 (vertical axis) rat embryos using
GeneSpring. Up- and down-regulated genes are indi-
cated in red and green, respectively. The use of four
replicates greatly improved erratic patterns in areas of
low signal intensity, in which data were widely spread in
each of these analyses (data not shown). We did not
exclude genes with the MAS-absent (A) flag from subse-
quent analyses because some of the genes judged to be
absent (A) in all samples, such as Ncam1, are known to
have a low expression level and/or a restricted expres-
sion pattern in the E11.5 hindbrain. For accurate selec-
tion of differentially expressed genes, we performed t-
tests using the cross-gene error model for all genes
instead of using the fold change threshold. The 1,421
selected genes with p-values less than 0.05 consisted of
737 up-regulated and 684 down-regulated genes (Figure
1B; Additional file 2). The up- and down-regulated
genes that had relatively smaller (< 2-fold) changes
(within the blue lines in Figure 1A, B) passed the t-test
at middle and higher signal intensities (> 0.3 in both
WT and rSey
2/rSey
2), but were discarded at the lower
signal intensity (< 0.3 in either WT or rSey
2/rSey
2).
Thus, this strategy enabled us to identify up- and down-
regulated genes regardless of expression levels and fold
changes.
Gene ontology analyses of Pax6 downstream molecules
To categorize the differentially expressed genes, we per-
formed gene ontology (GO) analyses. GO annotations
were collected for the 1,421 selected genes, and 144, 160
and 160 genes were assigned one or more GO terms:
cellular component (CC), molecular function (MF), and
biological process (BP), respectively (see Additional file
3). Downstream molecules corresponding to most of the
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Page 2 of 16Figure 1 Scatter plots of gene expression levels in the hindbrain of E11.5 rSey
2/rSey
2 and WT rat embryos. (A) Average per chip
normalized signal intensities for all probe sets on GeneChip 230A and 230B are plotted using GeneSpring software. The dots are colored
according to their per gene normalized values for rSey
2/rSey
2 (vertical) compared to WT (horizontal): high (red), equal (yellow) and low (green).
The reliability of the data is indicated by a dark-light gradient; genes with higher confidence are deeper in color. The three blue lines correspond
to 2-fold up-regulation (+2), no change (± 1) and 2-fold down-regulation (-2) for rSey
2/rSey
2 compared to WT. (B) The 1,421 differentially
expressed genes selected by t-test using the cross-gene error model (p < 0.05). Gray and brown lines indicate the normalized signal as 1 and
0.3, respectively. Cyan, black, magenta and blue dots with gene names correspond to the probe sets that are listed in Additional file 4 and
displayed in Figure 3. The colors of the dots reflect expression levels and fold change values: cyan, high expression (normalized signal > 1) with
more than a 2-fold change; black, high expression with less than a 2-fold change; magenta, medium expression (normalized signal 0.3 to 1); and
blue, low expression (normalized signal < 0.3) with more than a 5-fold change. The seven probe sets indicated with arrows correspond to four
of the most down-regulated genes, which are shown in situ in Figures 4 and 5.
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the analyses. Because the GO terms provided by the GO
consortium are based on a hierarchical clustering, we
chose the most suitable GO term for each gene in order
to simply sort them into the GO categories shown in
Figure 2. Categorization by the GO term CC revealed
that 75/144 (52%) genes encoded membrane compo-
nents (green in Figure 2A). Regarding the MF term, 41/
160 (26%) and 12/160 (7.5%) genes coded for molecules
related to signal transducer (green in Figure 2B) and
channel (orange in Figure 2B) activities, respectively.
Genes (26/32, 81%) sorted into the “signal transduction”
category of the BP term (green in Figure 2C) overlapped
with the genes categorized as signal transducer and
channel activities of the MF term. These results suggest
that many downstream molecules of Pax6 that are
located in or near the membrane function as signal
transducers (e.g., Htr4, Gabrr2, Gna15 and Fgf9)t h a t
regulate various signaling cascades. Similarly, 23/144
(16%) of the gene products were found to localize in the
nucleus (red in the CC, Figure 2A), and 21/160 (13%)
genes encoded transcription factors or DNA binding
molecules (purple in the MF, Figure 2B). As expected,
15/21 (71%) of these transcription factors or DNA bind-
ing molecules were classified in the “development” cate-
gory of the BP term (e.g., Nkx6-1, Ascl1, Neurog1 and
Klf5, red in Figure 2C). Thus, the GO analyses demon-
strated that Pax6 is involved in various signaling path-
ways where it regulates the expression of many
receptors, receptor binding molecules, transporters and
transcription factors.
Confirmation of differential expression of downstream
genes
Next, we used quantitative RT-PCR (Q-PCR) to confirm
the expression levels of the differentially expressed
genes identified in the microarray comparison analyses;
Q-PCR was performed using the primers listed in Addi-
tional file 4. The genes selected for Q-PCR analysis are
indicated by cyan, black, magenta and blue dots in Fig-
ure 1B.
Among the highly expressed genes (normalized inten-
sity of more than 1.0), all of the genes with two-fold or
greater down-regulation (cyan dots in Figure 1B)
showed a similar down-regulation in Q-PCR (Figure 3A,
A’). The Fabp7 gene, which we have previously reported
to be down-regulated in the E12.5 rSey
2/rSey
2 rat
embryo [8], showed more than 50-fold down-regulation
in the hindbrain at E11.5 (Figure 3A). Another probe set
for EST/Fabp7, located in the intronic sequence of the
Fabp7 gene, also indicated a relatively high level of
down-regulation in the two comparative microarray ana-
lyses (more than 5-fold) (Figure 3D). In addition, using
Q-PCR we were able to confirm an actual decrease in
expression for 13 selected genes that exhibited less than
2-fold down-regulation in the microarray analyses (black
d o t si nF i g u r e1 B ;F i g u r e3 B ) .H o w e v e r ,o n e( E S T /
Zfp207) of three genes that were found to be up-regu-
lated in the microarray exhibited down-regulation in the
Q-PCR analysis (Figure 3A’, B).
With respect to the selected genes that had a lower
normalized intensity (between 0.3 to 1.0; magenta dots
in Figure 1B), the seven genes that were down-regulated
in the microarray comparison were confirmed to be
down-regulated by Q-PCR, while two of four up-regu-
lated genes were not amplified well (Figure 3C). Other
ESTs for Camk2n1, Hes5 and Ctnnd2 exhibited similar
down-regulation as shown in Figure 3B, suggesting that
the normalized intensity obtained from the quadruple
array samples was reliable in down-regulated genes.
Of the selected genes that had an exceptionally low
normalized intensity (less than 0.3; blue dots in Figure
1B), the three down-regulated genes EST/Gdf11,E S T /
Cxcl5 and Unc5h1, which showed a similar fold change
to that obtained with the probe set for intronic EST/
Fabp7, also exhibited down-regulation in the Q-PCR
analyses (Figure 3D). On the other hand, of the two
selected genes that were up-regulated in the microarray,
one (EST/Mtmr1) was down-regulated on Q-PCR and
the other (Svs2) could not be amplified (Figure 3D). The
comparative Q-PCR analyses suggest that down-regula-
tion was more accurately reflected than up-regulation in
our microarray analyses.
In further analyses of Pax6 downstream molecules, we
focused on four down-regulated genes, Fabp7, Dbx1,
Cyp26b1 and Unc5h1, that demonstrated higher expres-
sion in the wild type, as confirmed by both microarray
(arrows in Figure 1B) and Q-PCR (Figure 3A, A’, D).
Expression patterns of Pax6 and its downstream genes in
E11.5 hindbrain
Whole mount in situ hybridization (WISH) was per-
formed on E11.5 embryos of three genotypes (WT,
rSey
2/+ and rSey
2/rSey
2) to examine the localization of
the mRNA transcribed from four of the most down-
regulated genes (i.e., Fabp7, Dbx1, Unc5h1 and
Cyp26b1)a sc o m p a r e dt oPax6 transcripts and protein
(Figure 4). Although Pax6 mRNA was detected in the
rSey
2/rSey
2 and rSey
2/+ embryos in an expression pat-
tern similar to that of WT embryos (Figure 4A), the
Pax6 protein was undetectable in the rSey
2/rSey
2 embryo
and seemed to be reduced in the rSey
2/+ embryo as
compared with WT (Figure 4B); this result was consis-
tent with Western blot results from a previous study [2].
In the WT embryo, expression patterns of Fabp7 were
quite similar to those of Pax6; strong signal was
observed in the hindbrain and, at week one, in the dor-
sal telencephalon, a part of the diencephalon, as well as
the spinal cord (Figure 4A, C). In the E11.5 rSey
2/rSey
2
embryo, expression of Fabp
7 disappeared (Figure 4C), as
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Page 4 of 16Figure 2 Gene ontology (GO) analyses of the genes that were differentially expressed between rSey
2/rSey
2 and WT rat hindbrains at
E11.5. Annotated genes were selected by t-test using the cross-gene error model (p < 0.05). The genes are categorized by the following GO
terms: cellular component (144, A), molecular function (160, B) and biological process (160, C), and are displayed in doughnut charts. Internal
color arcs indicate the total rates for each category: (A) membrane (green, 52.1%), cytoplasm (blue, 29.9%) and nucleus (red, 16.0%); (B) signal
transducer (green, 25.6%), catalytic (blue, 25.6%), binding (red, 25.0%) and transporter (yellow, 16.9%) activities; and (C) development (red, 26.9%),
signal transduction (green, 20.0%), transport (yellow, 18.1%), and metabolism (blue, 16.9%). The details of the annotated genes and GO terms are
shown in Additional file 3.
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Page 5 of 16Figure 3 Comparison of fold changes of up- or down-regulated genes in the E11.5 rSey
2/rSey
2 rat hindbrain using three analysis
methods. The fold changes of the genes selected (p < 0.05) from the comparative analyses of the microarray data by GeneSpring (blue bar)
and Microarray Suite (yellow bar) (shown in Additional file 1) are indicated with their real-time Q-PCR gene expression ratios (pink bar). The Q-
PCR experiments were performed with LightCycler using the primers listed in Additional file 4. The genes are listed in the order of their fold
change values calculated by GeneSpring. (A, A’) Thirteen highly expressed genes showing high normalized signal intensity (> 1.0) in either or
both conditions and high fold change value (> 2.0) in GeneSpring analyses. Since the down-regulation of Fabp7 is dramatic, the data are shown
separately in (A). (B) Thirteen down-regulated genes and one up-regulated gene selected from the highly expressed genes with a fold change
less than 2.0 in GeneSpring analyses. (C) Seven down-regulated genes and four up-regulated genes selected from genes showing medium
normalized signal intensity (0.3-1.0) in both conditions. (D) Four down-regulated genes and two up-regulated genes with a high fold change (>
5.0), but a low expression level (normalized signal < 0.3). Groups of genes categorized in (A, A’), (B), (C) and (D) correspond to cyan, black,
magenta and blue dots, respectively, in Figure 1B.
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Page 6 of 16previously reported for E12.5 embryos [8]. Moreover,
the expression of Fabp7 seemed to be entirely reduced
in the rSey
2/+ embryo as compared with the WT
embryo (Figure 4C), suggesting that the amount of Pax6
protein is critical for the induction of the Fabp7 gene.
Dbx1, which encodes a homeodomain transcription
factor, is expressed in interneuron progenitor cells in
the hindbrain and shows reduced expression in the
E12.5 rSey
2/rSey
2 h i n d b r a i n[ 1 6 ] .A ss h o w ni nF i g u r e
4D, Dbx1 expression in the rSey
2/+ embryo did not dif-
fer from that of the WT embryo at E11.5. However,
Dbx1 expression in the rSey
2/rSey
2 embryo was greatly
reduced, specifically in the diencephalon, hindbrain and
spinal cord; these regions lack Pax6 function, as indi-
cated by the lack of Pax6 protein in the rSey
2/rSey
2
embryo (Figure 4D).
Unc5h1 is a Netrin-1 receptor that is initially
expressed in neuronal progenitor cells in the ventral
hindbrain [19]. Unc5h1 mRNA was detected in part of
the forebrain as well as in the hindbrain and spinal cord
in the E11.5 WT embryo; the expression domain was
dorsally widened in the caudal hindbrain and anterior
spinal cord (Figure 4E). Unc5h1 expression was reduced
in the rSey
2/+ embryo and was entirely absent in the
rSey
2/rSey
2 embryo (Figure 4E).
Cyp26b1 is an RA-catabolizing enzyme that regulates
RA signaling by promoting its degradation [20].
Cyp26b1 showed a rhombomere-specific expression pat-
tern in the WT hindbrain (Figure 4F), corroborating a
previous report in mouse embryos [21]. Cyp26b1
expression in the rSey
2/+ embryo did not differ from
that of the WT embryo, whereas it was decreased speci-
fically in the caudal region of the rSey
2/rSey
2 hindbrain
(Figure 4F).
The above results indicate that not only Fabp7 and
Dbx1 but also Unc5h1 and Cyp26b1 are good candidates
for Pax6 downstream target molecules in the developing
CNS. To ascertain the detailed expression of these
downstream genes in the E11.5 hindbrain, we prepared
‘open-book’ samples of this tissue (Figure 5). Double
staining for Dbx1 and Pax6 demonstrated that expres-
sion of Dbx1 in the interneuron progenitor domain
along the anterior-posterior axis overlapped with Pax6
in both WT and rSey
2/+ hindbrains (Figure 5A, B).
Dbx1 expression was dramatically reduced throughout
the rSey
2/rSey
2 hindbrain with the exception of r1
(asterisk in Figure 5C), in which Pax6 was not
expressed. Unc5h1 expression disappeared in the rSey
2/
rSey
2 hindbrain in the ventral neuron progenitor
domains and in the dorsal part of r7, where Pax6 was
not detected at E11.5 (Figure 5F). Cyp26b1 expression
was altered specifically in the dorsolateral region of r5
and r6 in the rSey
2/rSey
2 hindbrain (indicated by arrow-
heads in Figure 5I, L). Thus, we consider these three
Figure 4 In situ staining of mRNA for down-regulated genes in
E11.5 rat whole embryos. (A) Whole mount in situ hybridization
(WISH) using an antisense RNA probe for Pax6 [47]. Localization of
Pax6 mRNA (blue-violet) was detected in the forebrain, hindbrain
and spinal cord of all embryos of the three genotypes. (B)
Immunostaining of E11.5 rat embryos with the monoclonal
antibody against the PD of Pax6 [14]. The localization of the Pax6
protein (brown) is nearly identical to that of Pax6 mRNA in WT and
rSey
2/+ embryos. The expression of the Pax6 protein is reduced in
the rSey
2/+ embryo and is not detected in the rSey
2/rSey
2 embryo.
(C-F) WISH using probes for the down-regulated genes. Expression
of Fabp7 (C) and Unc5h1 (E) is reduced in rSey
2/+ embryos and not
present in rSey
2/rSey
2 embryos. While there were no significant
differences found between WT and rSey
2/+ embryos with respect to
the expression of Dbx1 (D) and Cyp26b1 (F), the expression of these
mRNAs was markedly decreased in the hindbrain (D, F) and spinal
cord (D) of the rSey
2/rSey
2 embryo. (G) WISH using a probe for
RARb. The expression of RARb is up-regulated in the rSey
2/+ embryo
and is up-regulated to a greater extent in the rSey
2/rSey
2 embryo.
Scale bar: 1 mm.
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Page 7 of 16Figure 5 Double in situ staining of mRNAs for down-regulated genes and Pax6 in the E11.5 rat hindbrain. The expression sites of Dbx1,
Unc5h1 and Cyp26b1 (blue-violet in A-I and red in J-L) were compared with that of Pax6 (pink in A-I and blue in J-L) in WT (A, D, G, J), rSey
2/+
(B, E, H, K) and rSey
2/rSey
2 (C, F, I, L) hindbrains in ‘open-book’ preparations. (A-C) Dbx1 expression is decreased throughout the interneuron
progenitor domain of the rSey
2/rSey
2 hindbrain with the exception of r1, where Pax6 is not expressed (asterisk in C). (D-F) Unc5h1 expression
disappears in the somatic motor neuron progenitor domain and in the dorsal region of r7 in the rSey
2/rSey
2 hindbrain (F). (G-L) Cyp26b1
expression is specifically altered in the dorsolateral region of r5 and r6 in the rSey
2/rSey
2 hindbrain (arrowheads in I and L). r1 to r7 indicate the
individual rhombomeres of the hindbrain. Scale bar: 500 μm.
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targets of Pax6. We performed further detailed analyses
focusing on Cyp26b1 because this gene product is
involved in RA metabolism, which is an important ele-
ment in the anterior-posterior patterning of the
hindbrain.
Abnormal development of posterior rhombomeres in the
rSey
2/rSey
2
To explore the rhombomere-specific alteration of
Cyp26b1 expression, several markers were examined by
double-color WISH in E11.5 WT, rSey
2/+ and rSey
2/
rSey
2 hindbrains (Figure 6). Hoxb1 expression in r4 did
not show any change in the three genotypes (Figure 6A-
C), suggesting that r4 was intact. Krox20 expression was
observed in r5 at this stage in the rat embryo (Figure
6D-F). In the rSey
2/rSey
2 hindbrain, this Krox20-positive
r5 region seemed to expand along the anteroposterior
axis (Figure 6F; also see Figure 6J-L). A similar change
in r5 morphology was also detected in the rSey
2/rSey
2
hindbrain using a probe for EphA4, which was expressed
in r3 and r5 (Figure 6G-I). r6 was found to be intact in
the rSey
2/rSey
2 hindbrain through the use of an
EphrinB2 probe (data not shown).
Because the Cyp26b1 enzyme metabolizes RA, we
investigated the expression of retinoic acid receptor b
(RARb), a gene transcriptionally induced by RA [22,23].
We expected that down-regulation of Cyp26b1 in the
rSey
2/rSey
2 hindbrain might induce up-regulation of
RARb in r7 and/or an anterior shift of RARb to r5/6.
Although we did not detect as i g n i f i c a n ti n c r e a s ei n
RARb expression in our microarray analyses (Figure 1),
our in situ analyses revealed a relatively intense signal
for RARb mRNA (Figure 4G) with no obvious anterior
shift (Figure 6L). These results suggest that loss of Pax6
function might have resulted in slightly abnormal RA
signaling, which, in turn, might cause defects in the
anterior-posterior patterning of the hindbrain.
Discussion
Advantages of our comparative microarray analyses
We performed comprehensive transcriptional profiling
analyses to search for downstream genes regulated by
the Pax6 transcription factor in the E11.5 hindbrain of
WT and rSey
2/rSey
2 embryos using commercial high-
density oligonucleotide arrays. After collecting four
pools of 40 hindbrains dissected from E11.5 rat embryos
of each genotype, we prepared four sets of cDNA pools
for comparative microarray analyses. The advantages of
our “pooled method” are: (1) the minimization of indivi-
dual differences in embryonic stage, size and gene
expression level and (2) the isolation of a sufficient
amount of RNA for microarray analyses without unna-
tural amplification, even from small embryos. We
believe that this “pooled method,” although laborious,
significantly improves the acquisition of reliable micro-
array data. Furthermore, comparison analyses of quadru-
plicate samples using two computational methods
allowed us to identify differentially expressed genes that
have relatively small fold changes, such as Camk2n1,
Hes5 and Ctnnd2 (Figure 3B, C), or low expression
levels, such as Gdf11 and Cxcl5 (Figure 3D). Confidence,
as shown by color strength in Figure 1, indicates that
the selected genes with a relatively lower fold change
were also considered reliably identified in our microar-
ray analyses.
We have succeeded in minimizing false positive/nega-
tive candidates for differentially expressed genes, espe-
cially with respect to down-regulated genes. All down-
regulated genes showed a similar trend in two compara-
tive microarray analyses and Q-PCR (Figure 3). Only
two of 40 tested genes exhibited expression levels in Q-
PCR that were inconsistent with their signal intensities
from the microarray analyses. We could not perform Q-
PCR for the three genes whose signal intensities were
less than 1.0. These five genes were up-regulated in the
microarray analyses. One reason for this difference is
that we designed primers for Q-PCR based on full-
length mRNA sequences or Ensembl/N-SCAN/Genscan
prediction and not on the same EST sequences used for
the probe sets. Transcription of EST domains and full-
length mRNA as well as amputation/digestion of mRNA
after transcription might be differentially regulated. The
other reason for this difference might be the develop-
mental stage of our samples. We used E11.5 rat hind-
brains (which correspond to E9.5 in the mouse) in order
to look for downstream genes that are directly regulated
by Pax6. This stage occurs only 24 h after the onset of
Pax6 expression. Therefore, down-regulated expression
in rSey
2/rSey
2 is reproducible whereas up-regulated
expression, which may be indirect, is not. Reflecting on
previous results from the microarray analyses of Sey/Sey
mice, Duparc et al. [10] analyzed E9.5 Pax6
LacZ/LacZ
mouse forebrain and showed far fewer up-regulated
genes as compared with down-regulated genes in a scat-
ter plot. Other profiling analyses, in which embryos at
later stages were used, have reported a larger number of
up-regulated genes in Sey/Sey mouse telencephalon
[11,12]. This finding might be attributable to the indir-
ect regulation of an increasing number of genes by sig-
nal pathway molecules and/or transcription factors that
are downstream of Pax6 at later stages of development,
after the initiation of Pax6 expression. In our analyses
using E11.5 rSey
2/rSey
2 hindbrain, we obtained a slightly
larger number of up-regulated genes (737) as compared
with down-regulated genes (684), although the number
of up-regulated genes with high signal intensities (68,
9.2%) was smaller than that of down-regulated genes
(194, 28%) (Figure 1). This result also implies the
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Page 9 of 16Figure 6 The rhombomere 5 region is broadened in the rSey
2/rSey
2 hindbrain. (A-F) The expression sites of Hoxb1 and Krox20 (blue) were
compared with that of Cyp26b1 (red) in WT (A, D), rSey
2/+ (B, E) and rSey
2/rSey
2 (C, F) hindbrains. (A-C) Hoxb1 expression (as a marker of r4) is
unchanged in the rSey
2/rSey
2 hindbrain (C). (D-F) Krox20 expression (as a marker of r5; cannot detect in r3 at E11.5) overlaps with Cyp26b1
expression in the dorsolateral domain of the WT and rSey
2/+ hindbrain (D and E). The r5 region is slightly broadened in the rSey
2/rSey
2 hindbrain
along the anterior-posterior axis (F). (G-I) EphA4 expressed in both r3 and r5 of the E11.5 hindbrain. EphA4 expression domains (blue) are
broadened only within the r5 region of the rSey
2/rSey
2 hindbrain (I) as compared to the WT (G). (J-L) The expression site of RARb (blue) was
compared with that of Krox20 (red) in WT (J), rSey
2/+ (K) and rSey
2/rSey
2 (L) hindbrains. Krox20 expression is posteriorly expanded in the rSey
2/
rSey
2 hindbrain (L), although the anterior border of RARb expression (anterior edge of r7 in L) is not altered. Scale bar: 500 μm.
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Page 10 of 16delicacy of the molecular networks that lie downstream
of Pax6 because the onset of Pax6 expression in the
hindbrain occurs slightly earlier than in the forebrain.
During the course of our study, we identified multiple
probe sets on the RAE230 array that recognized differ-
ent sequences of the same genes and exhibited widely
different signal intensities; these included the probe sets
for Fabp7, Unc5h1, Cyp26b1, Camk2n1, Hes5 and
Ctnnd2 (Figure 1). The variability in signal intensity
among multiple probe sets may be due to (1) splicing
variants, (2) different gene names and (3) ESTs that had
not been integrated into the corresponding mRNA
within the rat UniGene database, which was used for
designing the probe sets. We used poly(A)
+ RNA, not
total RNA, as a template, which might have resulted in
a discrepancy in the signal intensities of different probes
that were designed to recognize 3’ or 5’ sites of relatively
long genes.
Downstream factors of Pax6 clarified by GO analyses
We performed GO analyses to elucidate the overall fea-
tures of the molecules downstream of Pax6. The GO
analyses shown in Figure 2 revealed that various signal-
ing molecules were located downstream of Pax6. The
l a r g eq u a n t i t yo fi n f o r m a t i o nf r o mt h eG Oa n a l y s e s
enabled us to search for interesting features of the
downstream factors of Pax6. For example, we found
transcriptional changes in Sst, Ceacam1, Cspg3, Ascl1,
Unc5h1, Nrg1 and Thy1, which are categorized in the
“cell migration” group of the GO BP term (see Addi-
tional file 3). Because Pax6 was reported to regulate
granule cell polarization and migration in the developing
cerebellum [15], some of these factors might be involved
in the molecular mechanisms of these events.
Gohlke et al. reported GO analyses of transcriptional
profiling using mice deficient in or overexpressing Ngn2
and Mash1, key transcriptional factors that promote
neurogenesis [24]. Genes were selected that were up-
regulated in telencephalon tissues transfected with Ngn2
or Mash1 (i.e., samples 18 h after electroporation at
E10.5) and down-regulated in telencephalon tissues of
Ngn2 and/or Mash1 knockout mice at E13.5. Among
the 131 and 35 genes that had GO annotations and
were considered to be regulated by Ngn2 and Mash1,
respectively, 32% and 37% of the genes, respectively,
were categorized with the GO term “signal transduc-
tion/receptor”, and 14% and 20% of the genes, respec-
tively, were tagged with “regulation of transcription”.
These results agree with our list of candidate genes that
might be regulated by Pax6 in the E11.5 rat hindbrain;
such agreement is quite reasonable considering that
Ngn2 is reported to be directly induced by Pax6 and to
repress Mash1 [25,26].
Downstream genes previously reported in Pax6 mutants
We previously reported that the development of cranial
motor neurons in the rSey
2/rSey
2 hindbrain is abnormal;
two somatic motor nerve types–t h ea b d u c e n t( V I )a n d
hypoglossal (XII) motor neurons–are missing when
Pax6 function is lost [1] owing to the abnormal forma-
tion of progenitor domains for these ventral motor neu-
rons along the dorsoventral axis [16]. We also found
that cadherin7/cadherin20-expressing nXII motor nuclei
are absent in E18.5 rSey
2/rSey
2 rats [27]. The expression
levels of genes that encode progenitor domain-specific
homeodomain proteins and the secreted molecule
Wnt7b are altered in the ventricular zone of the E12.5
mutant hindbrain [1,16], although the identity of the
other molecules involved in the downstream network of
Pax6 that affects hindbrain development remains
unclear.
In this microarray study, the down-regulation of
Fabp7 and Dbx1, which has been previously described
[8,16], was confirmed. Expression of Fabp7 in the hind-
brain showed a greater reduction at E11.5 than at E12.5,
suggesting that regulation of Fabp7 at the earlier stage
is more dependent on Pax6 function. A previous paper
reported a loss of expression of Ngn2 in the somatic
motor neuron progenitor domain in the E12.5 rSey
2/
rSey
2 hindbrain [28]. In our analyses using E11.5 hind-
brains, we could not find a significant difference in
Ngn2 expression (p > 0.05; 1.4-fold by GeneSpring, 1.2-
fold by MAS and 1.6-fold by Q-PCR). We also com-
pared Ngn2 expression in the E11.5 hindbrain via
WISH, but there was no remarkable difference between
WT and rSey
2/rSey
2 (Takahashi and Osumi, unpublished
data). These findings suggest a temporally distinct regu-
lation of Ngn2 by Pax6.
Hes family members (reviewed in [29]) and Bhlhb5 are
other important bHLH transcription factors related to
neurogenesis. In our microarray analyses, probe sets for
Hes5 suggested 1.8- and 1.9-fold down-regulation (p <
0.05, Figure 3B, C), although Hes1 and Hes3 expression
levels did not differ between WT and rSey
2/rSey
2.
Bhlhb5 expression was also significantly down-regulated
in the rSey
2/rSey
2 hindbrain (2.1-fold, p <0 . 0 5 ,F i g u r e
3A’), similar to previous results of transcriptome ana-
lyses of the Sey/Sey mouse telencephalon [11]. Bhlhb5
was reported to be expressed in the mouse cortical pri-
mordium and to control the subtype specificity of pro-
jection neurons [30]. Furthermore, Ngn2, a downstream
gene of Pax6, was shown to be upstream of Bhlhb5
[31,32]. Meanwhile, in humans, BHLHB5 is expressed in
the cerebellum and can repress Pax6 expression [33].
Therefore, it is presumed that Pax6 regulates the prolif-
eration and differentiation of neural stem/progenitor
cells through the organization of bHLH transcription
factors in a nested manner.
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Page 11 of 16Although we could not detect down-regulation of
Wnt7b in the E11.5 hindbrain as found at E12.5 [1],
another member of the Wnt family, Wnt7a, showed sig-
nificant down-regulation (Figure 3C) as reported in the
mouse forebrain [11]. Therefore, the regulation of
downstream genes by Pax6 seems to be quite context-
dependent; Pax6 may differentially regulate the expres-
sion of target molecules according to stage and tissue.
Novel downstream genes of Pax6 and their relationship
to the anteroposterior patterning of the hindbrain
In the present study, we identified novel candidates for
Pax6 downstream molecules. First, Unc5h1 expression
was abolished in the rSey
2/rSey
2 hindbrain in the ventral
expression domain of Pax6 within r2 to r7 (Figure 4A, E
and 5F). Furthermore, Unc5h1 expression was detected
in the dorsal part of r7 and in the spinal cord (Figure
4E and 5D, E), where Pax6 was not detected at E11.5
(Figure 4A and 5F); however, Pax6 was expressed at an
earlier stage in WT and rSey
2/+ (data not shown). In
the hindbrain of rSey
2/rSey
2, almost no expression of
Unc5h1 was revealed by WISH (Figures 4E and 5F).
From these results, we suspect that expression of
Unc5h1 is regulated by Pax6 prior to E11.5. In the cere-
bellum of the Pax6 homozygous mutant mouse, Unc5h3
expression is completely absent in the external granule
cell layer [14]. These findings may suggest a common
regulation of expression of duplicated Unc5 family genes
by Pax6.
Another Pax6 downstream candidate is Cyp26b1, an
RA catabolic enzyme. A lack of Cyp26b1 results in the
dispersion of the RA signal in the developing limb [34].
RA is thought to act as a diffusible morphogen that pat-
terns the hindbrain along the anteroposterior axis, and
degradation of RA by Cyp26s is a major determinant of
spatiotemporally specific RA signaling (reviewed in
[35]). RA also alters the migration patterns of cranial
neural crest cells in the rat embryo [36]. We found that
Cyp26b1 expression was specifically abolished in r5 and
r6 in the rSey
2/rSey
2 hindbrain (Figure 5I, L). These two
rhombomeres express the kreisler gene, which encodes
the MafB transcription factor, a protein with a critical
role in caudal hindbrain patterning [37,38]. Maf partners
with Pax6 for synergistic transcriptional activation of
several crystallin and glucagon genes [39,40]. Therefore,
the expression of Cyp26b1 in r5 and r6 is assumed to be
regulated by Pax6 together with MafB.
Although knockout mice lacking Cyp26b1 function
show no major defects in the hindbrain [34,41], two
reports describe the contribution of Cyp26b1 to hind-
brain development in zebrafish; Hernandez et al. found
that injection of a cyp26b1 antisense morpholino oligo-
nucleotide (MO) into cyp26a1 mutants caused expan-
sion of r4 and an anterior shift of the r6/7 boundary
[42]. Additionally, Reijntjes et al. showed, by preventing
the splicing of the cyp26b1 transcript in WT embryos
using another cyp26b1 MO, a reduced rhombomere size
and defects in craniofacial structures at later stages [43].
In detailed analyses of rhombomeres using a Krox20
probe, we observed that the r5 region was broadened
anteroposteriorly to some extent (Figure 6F, L). This
result represents a novel finding that anterior-posterior
patterning of the hindbrain is altered in the Pax6
mutant. Consistent with this result, we found a slight
up-regulation of Krox20 (1.63- and 1.31-fold change
with two probe sets, but it should be noted that p >
0.05).
Recently, the Hoxd4 gene was reported to be a direct
target of Pax6. Hoxd4 expression in r7 and the spinal
cord is reduced to some extent in the Pax6 mutant
mouse embryo, and double knock-down of pax6a and
pax6b with MOs resulted in malformed rhombomere
boundaries and an anteriorized hoxd4a expression bor-
der in the zebrafish embryo [44]. In our microarray ana-
lyses, Hoxd4 showed slight down-regulation with
statistical significance (1.37-fold; p < 0.05), although its
expression level was quite high, even in the rSey
2/rSey
2
hindbrain (normalized intensity 3.332 vs. 4.581 in WT).
Therefore, we consider that a loss of Pax6 function
affects the anteroposterior patterning of r5 by Cyp26b1
down-regulation rather than by regulation of Hoxd4
gene expression.
The anteroposterior defect that we observed in the
Pax6 mutant hindbrain was very mild as compared with
that of phenotypes induced by excess RA (reviewed in
[45,46]). It would be interesting to determine how
mildly elevated levels of RA signaling affect rhombo-
mere formation and subsequent neural function.
Conclusions
We identified Unc5h1 and Cyp26b1 as novel down-
stream genes of Pax6 in the early development of the
hindbrain. In addition, the broadening of the r5 region
in Pax6 mutant embryos raises the possibility that Pax6
regulates the anterior-posterior patterning of the hind-
brain via activation of the RA-metabolizing enzyme
Cyp26b1.
Methods
Animals
The procedures for preparing rat Small eye (rSey
2)
mutant and normal Sprague-Dawley (WT) embryos and
for genotyping by mutation-specific PCR with genomic
DNA extracted from each yolk sac have been described
previously [2]. All experimental procedures described in
t h i ss t u d yw e r ea p p r o v e db yt h eC o m m i t t e ef o rA n i m a l
Experimentation of the Tohoku University Graduate
School of Medicine.
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Microarray analyses were performed using the Gene-
Chip Rat Expression Arrays RAE230A and 230B (Affy-
metrix), which contain 31,042 probe sets that were
designed from sequences in the UniGene database
(NCBI, Build 99). The probe sets on RAE230A consist
of the sequences from 4,699 full-length cDNAs, 700
non-ESTs and 10,467 ESTs. All 15,176 probe sets on
RAE230B were derived from EST sequences.
Total RNA was prepared using TRIZOL Reagent
(Invitrogen) from 40 hindbrains dissected from E11.5
Pax6 homozygous mutant (rSey
2/rSey
2)o rW Tr a t
embryos. Poly(A)
+ RNA was isolated with the Oligotex-
dT30 <Super> mRNA Purification kit (TaKaRa). The
RNA quality and concentration were confirmed by agar-
ose gel electrophoresis and NanoDrop spectrometry
(NanoDrop Technologies). The following method for
the preparation of target cRNAs is similar to that in our
previous report [8]. mRNA (2 μg) and a T7-linked oligo
(dT) primer were used to generate first-strand cDNA
with the SuperScript Choice System (Invitrogen). After
second-strand synthesis, double-stranded cDNAs were
purified via phenol/chloroform extraction and ethanol
precipitation. In vitro transcription of the cDNA pools
was performed using a BioArray HighYield RNA tran-
script labeling kit (Enzo) in the presence of biotinylated
UTP and CTP, resulting in approximately 100-fold
amplification of biotin-labeled cRNAs. The cRNAs were
purified using RNeasy Mini Spin Columns (QIAGEN)
and fragmented at 94°C for 35 min in fragmentation
buffer (30 mM magnesium acetate, 100 mM potassium
acetate and 40 mM Tris-acetate, pH 8.1). The resultant
target cRNA fragments (20 μg) were mixed with spike
controls, divided into two sub-chips (RAE230A and
RAE230B Arrays), and hybridized with the oligonucleo-
tide probes on the GeneChip at 45°C for 16 h according
to the manufacturer’s recommendations. After washing
and streptavidin-phycoerythrin staining steps, fluores-
cence signals were enhanced with a biotinylated anti-
streptavidin antibody using the Affymetrix fluidics sta-
tion (EukGE-WS2 protocol) and detected with the Affy-
metrix GeneChip Scanner. Array images were assessed
by eye to confirm scanner alignment and the absence of
significant bubbles or scratches on the chip surface.
Experiments using 40 hindbrains were repeated four
times in each genotype, i.e., four pools of 40 hindbrains
per genotype were used for preparing four ‘target’ cRNA
pools per genotype, and each of the cRNA pools was
hybridized to one RAE230 array.
Using Microarray Suite (MAS) 5 (Affymetrix), we per-
formed absolute analyses for each chip to obtain raw
signal intensity data as well as present (P), absent (A)
and marginal (M) flags. In the MAS expression reports,
3’/5’ ratios for GAPDH and b-actin were confirmed to
be within acceptable limits (1.69 ± 0.69 and 1.73 ±
1.01), and BioB spike controls were found to be present
on all of the chips, with BioC, BioDN and CreX also pre-
sent in increasing intensity. In addition, four indepen-
dent sets of comparison analyses were performed using
MAS to obtain four signal log2 ratios of rSey
2/rSey
2 to
WT per gene. n was calculated as the average of the
four signal log2 ratios, and 2
n corresponds to the fold
change value of the gene.
Data analysis by GeneSpring software
In further analyses, all raw signal data were exported
from MAS .CHP files and imported to GeneSpring 7
software (Agilent). The raw data were transformed to
s e tm e a s u r e m e n t so fl e s st h a n0 . 0 1t o0 . 0 1i no r d e rt o
display all of the data on a logarithmic scale. In order to
fit the gene expression levels from the 230A and 230B
arrays, data were normalized against positive control
genes and genes common to both 230A and 230B. They
were then used in the following expression data ana-
lyses. The “fold change” value is the ratio of the average
normalized signal intensity of rSey
2/rSey
2 to that of WT
for up-regulated genes (rSey
2/rSey
2 > WT). In the case
of down-regulated genes (rSey
2/rSey
2 <W T ) ,t h ef o l d
change is the negative inverse ratio. Comparative ana-
lyses were performed using two confidence filters. First,
the data for all genes were normalized per gene for the
WT samples. Genes (737) with a t-test p-value from 0
to 0.05 were selected under the condition that the
cross-gene error model was active, but none of the mul-
tiple testing corrections was used. For the normalization
per gene for the rSey
2/rSey
2 samples, 688 genes passed
similar filtering conditions. The genes from the indivi-
dual filter steps were combined to generate a list of
1,421 genes. No significant change was detected for
Sox2, Shh or Pax3, which are expressed in the E11.5
hindbrain but not expected to be regulated by Pax6. In
the scatter plots, the dots are colored to reflect the
expression levels of the rSey
2/rSey
2 samples normalized
per gene for the WT samples, with color density indi-
cating reliability. Because the GeneChip RAE 230 gene
titles that were provided by Affymetrix were sometimes
incorrect, the master gene table for RAE 230 was
updated using GeneSpider, which automatically sub-
mitted each gene to three databases: Entrez Gene, Gen-
Bank and UniGene. If required, gene annotation was
manually submitted to multiple databases including
UCSC Genome Browser, NetAffx Analysis Center,
RefSeq and LocusLink using Gene Inspector. The GO
terms titled “GO cellular component”, “GO molecular
function” and “GO biological process” were used for
GO analyses and are listed in the three columns of the
updated master gene table for RAE230.
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Real-time quantitative PCR was performed using a
LightCycler (Roche), FastStart DNA Master SYBR Green
I (Roche) and the same double-stranded cDNA tem-
plates that were used in the microarray analyses. Primer
sequences for Fabp7 were described previously [8].
Other primer sets were designed to amplify about 100
to 150 bp cDNA fragments (Additional file 4) and were
synthesized by Nihon Gene Research Laboratories Inc.
The level of expression of each mRNA was normalized
against that of GAPDH, which was amplified as an inter-
nal standard from the same cDNA pool. To ascertain
whether the correct cDNAs were amplified, the size of
the PCR products was determined by agarose gel elec-
trophoresis, and then the sequences were verified by
direct sequencing of the amplified fragments using the
ABI310 at the Biomedical Research Core of Tohoku
University Graduate School of Medicine.
In situ hybridization and immunostaining
WISH as well as double staining with digoxigenin
(DIG)- and fluorescein isothiocyanate (FITC)-labeled
RNA probes were performed as described previously
[1,27]. To standardize expression levels, WT, rSey
2/+
and rSey
2/rSey
2 samples were processed simultaneously.
Each cDNA template for the DIG- and FITC-labeled
RNA probes was amplified by RT-PCR with the follow-
ing oligonucleotide primers: Unc5h1,5 ’-TGCCTGCA-
CACCGCTTCTTG-3’ and 5’-
GTGGGTGTCGTGTAGGCAGT-3’; Cyp26b1,5 ’-
ATGCTCTTTGAGGGCTTGGAGTTG-3’ and 5’-CTA-
CACCGTAGCACTCAACATGGC-3’; Hoxb1,5 ’-
CCGGACCTTCGACTGGATG-3’ and 5’-
GGTCGGAGGCCTCTCCAGC-3’; Krox20,5 ’-
GAGGCCCCTTTGATCAGATG-3’ and 5’-GGAGAG-
TAGAGGTGGTCCAG-3’. The cDNAs were inserted
into the EcoRV site of the pBluescript II SK(-) vector
(Stratagene). The mouse EphA4 cDNA was kindly pro-
vided by Dr. Y. Hara. The templates for rat Pax6 Region
B [47], rat Fabp7 [8], rat Dbx1 [16] and mouse RARb
[48] were described previously. Hindbrains were dis-
sected from the stained embryos, cut along the dorsal
midline, placed on a glass slide in an “open-book” con-
figuration and flattened by mounting cover slips. Whole
mount immunostaining was essentially performed as
described previously [36]. AD2.38, a monoclonal anti-
body raised against the PD of Pax6 [14], was a gift from
Dr. V. van Heyningen. A horseradish peroxidase (HRP)-
conjugated anti-mouse IgG antibody (CHEMICON) was
used as the secondary antibody. HRP was visualized by
the addition of its substrates, H2O2 and 3,3’-diamino-
benzidine (DAB; Dojindo), which resulted in a brownish
coloration. We confirmed the expression patterns by
performing these experiments at least three times.
Additional file 1: Schemes for the computation of fold change by
two comparison analyses. RAE230A and RAE230B are high-density
oligonucleotide array sub-chips of GeneChip Rat Expression Set 230 and
contain about 30,000 probe sets designed from sequences in the
UniGene database. Microarray Suite (MAS) 5 (Affymetrix) and GeneSpring
7 (Agilent) were employed as the analysis software for data processing,
normalization and comparison in two sets of analyses. (A) Four sets of
the rSey
2/rSey
2 and WT ‘target’ samples were hybridized to 230A and
230B arrays and scanned. The resultant signals were used in the
comparison analyses by MAS. Four independent comparison analyses per
sub-chip resulted in quadruplicate signal log2 ratios per gene. An
average of the four ratios was used to calculate the powers of two in
Microsoft Excel, which corresponded to the fold change for each gene in
the WT and rSey
2/rSey
2 samples. (B) Raw data of the signal intensity
derived from eight absolute analyses per sub-chip by MAS were
exported to GeneSpring and normalized to positive control genes and
genes common to both 230A and 230B arrays in order to compare the
expression levels of all genes on both sub-chips straightforwardly. Four
sets of normalized data were averaged individually for the WT and rSey
2/
rSey
2 samples. The ratio of the mean is equal to the fold change per
gene.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-6-
S1.PDF]
Additional file 2: Lists of down- (A) and up- (B) regulated genes with
significant differences (p < 0.05).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-6-
S2.XLS]
Additional file 3: Lists of genes with the Gene Ontology terms: GO
cellular component (A), GO molecular function (B) and GO biological
process (C).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-6-
S3.XLS]
Additional file 4: Sequences of primer sets for Q-PCR analyses of down-
and up- regulated genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-213X-10-6-
S4.XLS]
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